TKNO FY 2023 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena

TKNOAlpha Teknova, Inc.

$133M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$37M-11.4% YoY

Gross Profit

$10M28.1% margin

Operating Income

-$36M-96.9% margin

Net Income

-$37M-100.3% margin

EPS (Diluted)

$-1.16

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$27M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$129M

Total Liabilities

$39M

Stockholders' Equity

$90M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$41M	-11.4%
Gross Profit	$10M	$17M	-41.1%
Operating Income	-$36M	-$50M	+28.4%
Net Income	-$37M	-$47M	+22.5%